Asgari-Karschekani et al. observed that mucinous adenocarcinoma typically exhibits reduced or even negative CDX2 expression, in contrast to conventional adenocarcinoma, where CDX2 positivity is common [40]. This evidence concerns the gene CDX2 and mucinous adenocarcinoma.